Development of a radioiodinated apoptosis–inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies
Duiker, EW, Dijkers, ECF, Lambers Heerspink, H, de Jong, S, van der Zee, AGJ, Jager, PL, Kosterink, JGW, de Vries, EGE, Lub‐de Hooge, MN
Published in British journal of pharmacology (01.04.2012)
Published in British journal of pharmacology (01.04.2012)
Get full text
Journal Article
Preclinical characterisation of 111 In‐DTPA‐trastuzumab
Lub‐de Hooge, Marjolijn N, Kosterink, Jos G W, Perik, Patrick J, Nijnuis, Hugo, Tran, Ly, Bart, Joost, Suurmeijer, Albert J H, de Jong, Steven, Jager, Pieter L, de Vries, Elisabeth G E
Published in British journal of pharmacology (17.02.2009)
Published in British journal of pharmacology (17.02.2009)
Get full text
Journal Article
Abstract P5-03-06: Clinical value of 89Zr-trastuzumab PET in HER2-positive breast cancer patients with a clinical dilemma
Schröder, CP, Bensch, F, Brouwers, AH, Lub-de Hooge, MN, de Jong, JR, van der Vegt, B, Sleijfer, S, de Vries, EG
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus
Lub-de Hooge, M N, de Vries, E G E, de Jong, S, Bijl, M
Published in Annals of the rheumatic diseases (01.06.2005)
Published in Annals of the rheumatic diseases (01.06.2005)
Get full text
Journal Article
Endotoxin increases plasma soluble tumor necrosis factor-related apoptosis-inducing ligand level mediated by the p38 mitogen-activated protein kinase signaling pathway
Lub-de Hooge, Marjolin N, de Jong, Steven, Vermot-Desroches, Claudine, Tulleken, Jaap E, de Vries, Elisabeth G E, Zijlstra, Jan G
Published in Shock (Augusta, Ga.) (01.08.2004)
Published in Shock (Augusta, Ga.) (01.08.2004)
Get more information
Journal Article